Covid-19: ICMR revised strategy for testing in country

On Monday, The Indian Council of Medical Research (ICMR) has revised the strategy for testing coronavirus disease as the number of infected people crossed 1,00,000 mark today
The updated strategy proposes all symptomatic individuals who have recent history of travel tp abroad in the past 14 days to be tested. The strategy also says that test would also be conducted on all symptomatic contacts of laboratory confirmed cases, healthcare workers who are in the battlefield against Covid-19 and patients suffering from Severe Acute Respiatory Infection or SARI.

According to new ICMR testing strategy says, the high-risk contacts of a confirmed case should be tested once between day 5 and day 10 of coming into contact. All symptomatic patients with Influenza Like Illness (ILI) and patients who develop ILI symptoms should also be tested.

Dr Rajnikant Srivastava, the head of the Department of Research Management, Policy Planning and Communication at ICMR said, Till Friday, a total of 20,39,952 samples were tested in the country with 92,911 tests being conducted since Thursday 9 am.

  • Related Posts

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre